Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
JHOP - March 2024 Vol 14 Special Feature
Editorial
HOPA Abstracts
Editorial
Editorial
New Year, New HOP(A): Return of the Annual Conference Research Abstracts
Sara S. Kim, BS, PharmD, BCOP; Adam J. DiPippo, PharmD, BCOP
Read More
HOPA Abstracts
HOPA Abstracts
Biodistribution and Shedding Analysis Following RP1 Oncolytic Immunotherapy Dosing in Patients From the IGNYTE Clinical Trial: Implications for Oncology Pharmacists
Read More
HOPA Abstracts
Assessing Student Pharmacists’ Knowledge and Perceptions of Financial Toxicity Concepts Introduced in an Oncology Pharmacotherapy Course
Read More
HOPA Abstracts
Characterizing Second-Line and Beyond Treatments for Primary Central Nervous System Lymphomas
Read More
HOPA Abstracts
Coordinating Better Outcomes in Multiple Myeloma: An Educational Initiative to Elevate Pharmacist Leadership in Novel Antibodies and CAR-T Therapy
Read More
HOPA Abstracts
Darolutamide, Enzalutamide, and Apalutamide for Nonmetastatic Castration-Resistant Prostate Cancer Patients in the United States (DEAR): Comparative Real-World Evidence
Read More
HOPA Abstracts
Dosing, Safety, and Pharmacokinetics of Combination Therapy With Darolutamide, Androgen-Deprivation Therapy, and Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer in the ARASENS Study
Read More
HOPA Abstracts
Evaluating Patient Hesitancy in Receiving a Second Dose of Evusheld (Tixagevimab and Cilgavimab) for COVID-19 Prevention After a Food and Drug Administration Dosing Recommendation Update
Read More
HOPA Abstracts
First-Line Nivolumab + Ipilimumab + Chemotherapy Versus Chemotherapy Alone in Metastatic Non–Small Cell Lung Cancer: CheckMate 9LA 4-Year Clinical Update
Read More
HOPA Abstracts
Impact of Frailty on Outcomes After CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
Read More
HOPA Abstracts
Improving Post-Transplant Vaccination Compliance via Implementation of a Clinical Pharmacist–Managed Service
Read More
HOPA Abstracts
Incidence and Outcomes of Pneumonitis/Interstitial Lung Disease in Patients Receiving Trastuzumab Deruxtecan
Read More
HOPA Abstracts
Number-Needed-to-Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
Read More
HOPA Abstracts
Pharmacist-Led Monitoring for Patients Initiating PARP Inhibitor Therapy
Read More
HOPA Abstracts
Patient Perspective: Logistics of Intravenous Iron Administration and Adherence to Therapy
Read More
HOPA Abstracts
Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib for Advanced or Metastatic Breast Cancer in a Real-World Setting
Read More
HOPA Abstracts
Real-Life Study: Evaluation of the Safety of PARP Inhibitors in Ovarian Cancer at the Centre Hospitalier de l’Université de Montréal (CHUM)
Read More
HOPA Abstracts
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy (the REMEDY Trial)
Read More
HOPA Abstracts
Survey of PGY-2 Oncology Residency Program Directors to Assess Current Resources and Effects on Burnout
Read More
HOPA Abstracts
Taxane Titration: To Prime or Not to Prime?
Read More
HOPA Abstracts
Treatment and Outcomes Associated With Caplacizumab in the Management of Acquired Thrombotic Thrombocytopenic Purpura
Read More
HOPA Abstracts
Pharmacist Interventions Resulting From a Health System Specialty Pharmacy 14-Day Oncology Check-In Protocol
Read More
HOPA Abstracts
Comparison of the Efficacy of Generic Plerixafor Versus Mozobil as Adjunct Peripheral Blood Stem-Cell Mobilization Agents in Patients With Multiple Myeloma
Read More
HOPA Abstracts
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate vs Tacrolimus and Methotrexate as GVHD Prevention Following Allogeneic Stem Cell Transplant With Myeloablative Conditioning
Read More
HOPA Abstracts
Real-World Clinical Outcomes With Fostamatinib for the Treatment of Refractory Chronic Immune Thrombocytopenia
Read More
HOPA Abstracts
Unlocking Geographic Disparities in Lung Cancer Incidence Calls for Tailored Interventions and Pharmacist Partnerships
Read More
